Загрузка...
Bevacizumab Monotherapy as Salvage Therapy for Advanced clear cell Renal Cell Carcinoma (ccRCC) Pretreated with Targeted Drugs
Bevacizumab has shown benefit in the first line setting in combination with interferon; however, data on use as monotherapy are limited. This retrospective analysis of 71 patients assesses the efficacy of bevacizumab monotherapy in patients who progressed on other targeted drugs. Bevacizumab monothe...
Сохранить в:
| Опубликовано в: : | Clin Genitourin Cancer |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4965701/ https://ncbi.nlm.nih.gov/pubmed/26404107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.07.010 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|